Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2024-04-26 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
独立董事专门会议工作制度2024.04
Governance Information Classification · 95% confidence The document is titled '独立董事专门会议工作制度' which translates to 'Independent Directors Special Meeting Working System'. It outlines the governance rules and procedures for independent directors' meetings within the company, including their roles, meeting protocols, voting, and confidentiality obligations. The content focuses on governance structure and internal rules rather than financial data, audit results, or shareholder voting outcomes. There is no indication of financial statements, audit reports, or regulatory filings. The document is a governance-related policy document detailing internal governance practices and board procedures. Therefore, it fits best under Governance Information (CGR). The document length is 1985 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2024-04-26 Chinese
2023年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2023 年度董事会工作报告' which translates to '2023 Annual Board of Directors Work Report'. It details the board's activities, company governance, financial performance summary, board meetings, committee work, and plans for 2024. It includes financial figures but is primarily a narrative report on the board's work and governance rather than a full annual report or financial statements. The document length is about 5,313 characters, which is substantial and contains detailed information about board activities and governance. This fits the category of Board/Management Information (MANG), which covers announcements about board activities and management reports. It is not a full Annual Report (10-K) or Interim Report (IR) as it lacks comprehensive financial statements and detailed financial analysis. It is also not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) since it contains substantive content rather than just an announcement. Therefore, the best classification is MANG with high confidence.
2024-04-26 Chinese
关于调整第六届董事会专门委员会成员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the adjustment of members of a specialized committee within the company's sixth board of directors. It details changes in the audit committee membership and confirms compliance with governance rules. There is no financial data, no report attached or referenced as published, and no mention of voting results or other report types. This fits the category of Board/Management Information, which covers announcements of changes in the company's board or senior management structure.
2024-04-26 Chinese
股东大会议事规则2024.04
Governance Information Classification · 95% confidence The document is titled as the "Rules of Procedure for the Shareholders' General Meeting" of Yangpu Medical Technology Co., Ltd. It extensively details the procedures, powers, and regulations governing the conduct of shareholders' meetings, including the rights and responsibilities of shareholders, the board, and other parties involved. It does not contain financial statements, audit opinions, or management reports. It is a governance document outlining internal rules and meeting protocols rather than a report or announcement of financial results or corporate actions. Therefore, it fits best under Governance Information (CGR). The document length is substantial and contains detailed governance content, supporting a high confidence classification.
2024-04-26 Chinese
2023年年度财务报告
Annual Report Classification · 100% confidence The document is titled as the "2023 Annual Financial Report" of 阳普医疗科技股份有限公司, containing detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and an extensive audit report. The audit report is signed by a registered accounting firm and includes an unqualified opinion, key audit matters, and detailed auditor responsibilities. The document covers the full fiscal year ending December 31, 2023, and includes comprehensive financial data and analysis. The length of the document (15,000 characters) and the presence of full financial statements and audit opinions confirm it is the actual annual report, not just an announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-04-26 Chinese
非经营性资金占用及其他关联资金往来情况专项说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit-related report issued by an accounting firm (容诚会计师事务所) concerning non-operating fund occupation and other related party fund transactions of 阳普医疗科技股份有限公司 for the year ended December 31, 2023. It references the audit report issued on April 25, 2024, and complies with regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange. The document includes detailed tables of related party transactions and fund occupation balances, but it is not a full annual report or interim financial report. It is a standalone audit-related disclosure focusing on a specific regulatory requirement about related party fund transactions, consistent with the definition of an Audit Report / Information (AR). The document length is 3722 characters, which is relatively short but contains substantive audited financial data related to the audit scope. It is not merely an announcement or certification, so it should not be classified as RNS or RPA. FY 2023
2024-04-26 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.